IDiabetes platform-enhanced phenotyping of patients with diabetes for precision diagnosis, prognosis and treatment: study protocol for a cluster-randomised controlled study in Tayside, Scotland.

ABSTRACT:

Introduction and aim

Diabetes is a global health emergency with increasing prevalence and diabetes-associated morbidity and mortality. One of the challenges in optimising diabetes care is translating research advances in this heterogeneous disease into clinical care. A potential solution is the introduction of precision medicine approaches into diabetes care.We aim to develop a digital platform called 'intelligent Diabetes' (iDiabetes) to support a precision diabetes care model in Scotland and assess its impact on the primary composite outcome of all-cause mortality, hospitalisation rate, renal function decline and glycaemic control.

Methods and analysis

The impact of iDiabetes will be evaluated through a cluster-randomised controlled study, recruiting up to 22 500 patients

SUBMITTER: Lin Y 

PROVIDER: S-EPMC11605812 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature